Efficacy and safety of IVIG in CIDP: Combined data of the PRIMA and PATH studies

PRIMA Trial Investigators PATH, Ingemar S. J. Merkies, Ivo N. van Schaik, Jean-Marc Leger, Mika Saarela, Orell Mielke

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
JournalJournal of the Peripheral Nervous System
Volume24
Issue number1
Pages (from-to)48-55
Number of pages8
ISSN1085-9489
DOIs
Publication statusPublished - Mar 2019
MoE publication typeA1 Journal article-refereed

Fields of Science

  • CIDP
  • efficacy
  • IVIG
  • PATH
  • PRIMA
  • INFLAMMATORY DEMYELINATING POLYNEUROPATHY
  • INTRAVENOUS IMMUNOGLOBULIN
  • MAINTENANCE TREATMENT
  • OPEN-LABEL
  • PHASE-III
  • POLYRADICULONEUROPATHY
  • PREVALENCE
  • 3112 Neurosciences
  • 3124 Neurology and psychiatry

Cite this